Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Delcath Systems Inc (NASDAQ:DCTH)

0.338
Delayed Data
As of 3:50pm ET
 +0.0127 / +3.90%
Today’s Change
0.25
Today|||52-Week Range
1.92
-32.40%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$7.8M

Company Description

Delcath Systems, Inc. is a pharmaceutical and medical device company, which focuses on oncology and liver cancer therapy. Its proprietary drug and device combination product, Delcath Hepatic Delivery System is designed to administer high dose chemotherapy and other therapeutic agents to the liver, while controlling the systemic exposure of those agents. The company was founded on August 5, 1988 and is headquartered in New York, NY.

Contact Information

Delcath Systems, Inc.
1301 Avenue of the Americas
New York New York 10019
P:(212) 489-2100
Investor Relations:

Employees

Shareholders

Other institutional9.04%
Individual stakeholders4.38%
Mutual fund holders0.51%

Top Executives

Jennifer K. SimpsonPresident, Chief Executive Officer & Director
Barbra C. KeckSecretary & Principal Financial Officer
Jason A. RifkinVice President-Commercial Programs
John PurpuraEVP-Regulatory Affairs & Quality Assurance